Veeva CRM and Veeva OpenData Help the Life Sciences Industry Meet Compliance Requirements in Ohio
December 07 2017 - 7:03AM
Business Wire
Veeva Systems (NYSE: VEEV) today announced new capabilities in
Veeva CRM and licensing data in Veeva OpenData to help life
sciences organizations meet government regulations in Ohio.
Ohio law requires that all healthcare organizations (HCOs) have
Terminal Distributor of Dangerous Drugs (TDDD) licenses to
distribute the drugs that healthcare professionals (HCPs) are
prescribing. Provisions were added to the law this year to oversee
the interactions between pharmaceutical companies and HCOs and the
distribution of prescribed drugs.
Veeva CRM can now validate that an HCP is at an HCO with an Ohio
TDDD license number before a field representative provides a
product or sample. Together with Veeva OpenData, licensing data
flows seamlessly into Veeva CRM so representatives can ensure
pharmacies, hospitals, and medical practices are properly licensed
at the point of distribution.
“Veeva is helping the industry adapt faster to new and changing
regulations,” said Paul Shawah, senior vice president of commercial
strategy at Veeva. “Veeva CRM and Veeva OpenData bring together
license data with CRM so companies can address Ohio TDDD and
deliver products to prescribers without interruption.”
HCOs must have a valid license for the specific category of drug
they want to sample or prescribe. This creates additional
complexity for pharmaceutical companies to ensure prescribers are
affiliated with licensed organizations before they engage with an
HCP.
Veeva CRM helps sales representatives quickly confirm
affiliations between HCPs and HCOs and verify an organization has
an Ohio TDDD license. With Veeva OpenData, complete and accurate
HCP, HCO, and affiliation data is automatically cross-referenced
and validated in Veeva CRM.
Ohio TDDD is the latest example of Veeva CRM continuing to
evolve and help the industry keep pace with changing regulations as
they take effect. Veeva enables life sciences companies to adapt
quickly to compliance requirements faster and easier so they can
engage compliantly with HCPs without disruption.
To learn more about how Veeva enables customers to maintain
compliance with the Ohio TDDD law, visit: veeva.com/OhioTDDD.
Additional Information
For more information on Veeva CRM, visit: veeva.com/CRM
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the
global life sciences industry. Committed to innovation, product
excellence, and customer success, Veeva has more than 600
customers, ranging from the world’s largest pharmaceutical
companies to emerging biotechs. Veeva is headquartered in the San
Francisco Bay Area, with offices in Europe, Asia, and Latin
America. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the
market demand for and acceptance of Veeva’s products and services,
the results from use of Veeva’s products and services, and general
business conditions, particularly in the life sciences industry.
Any forward-looking statements contained in this press release are
based upon Veeva’s historical performance and its current plans,
estimates, and expectations, and are not a representation that such
plans, estimates, or expectations will be achieved. These
forward-looking statements represent Veeva’s expectations as of the
date of this press announcement. Subsequent events may cause these
expectations to change, and Veeva disclaims any obligation to
update the forward-looking statements in the future. These
forward-looking statements are subject to known and unknown risks
and uncertainties that may cause actual results to differ
materially. Additional risks and uncertainties that could affect
Veeva’s financial results are included under the captions, “Risk
Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on
Form 10-Q for the period ended October 31, 2017. This is available
on the company’s website at veeva.com under the Investors section
and on the SEC’s website at sec.gov. Further information on
potential risks that could affect actual results will be included
in other filings Veeva makes with the SEC from time to time.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171207005392/en/
Veeva SystemsRoger Villareal,
925-264-8885roger.villareal@veeva.comorVeeva SystemsLisa Barbadora,
610-420-3413pr@veeva.com
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Apr 2023 to Apr 2024